Login/Sign Up
₹24598.4*
MRP ₹29998
18% off
₹25498.3*
MRP ₹29998
15% CB
₹4499.7 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Consult your doctor
It is unknown whether Rafinlar 50 mg Capsule 28's interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Rafinlar 50 mg Capsule 28's is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Rafinlar 50 mg Capsule 28's. You should not become pregnant while you are taking Rafinlar 50 mg Capsule 28's for at least two weeks from the last dose of Rafinlar 50 mg Capsule 28's. Using effective birth control methods while on treatment with Rafinlar 50 mg Capsule 28's is suggested.
Breast Feeding
Unsafe
Inform your doctor if you are intending to breastfeed. Breastfeeding should be avoided while getting Rafinlar 50 mg Capsule 28's and for at least two weeks from the final dosage of administration.
Driving
Unsafe
Rafinlar 50 mg Capsule 28's may cause visual disturbances such as loss of vision or blurred vision in some patients. Hence, avoid driving and operating machines until you are completely alert.
Liver
Caution
If you have a pre-existing or a history of liver problems, tell your doctor before taking this medicine.
Kidney
Caution
If you have a pre-existing or a history of kidney problems, tell your doctor before taking this medicine.
Children
Caution
Rafinlar 50 mg Capsule 28's is not recommended for use in children below six years of age, as the safety and efficacy have not been established. In children above six years, it is used in the treatment of unresectable or metastatic solid tumours with BRAF V600E mutation when prescribed by your doctor.
About Rafinlar 50 mg Capsule 28's
Rafinlar 50 mg Capsule 28's is an anti-cancer medicine used in the treatment of various types of cancers. Cancer is a disease caused by the abnormal growth of cells that divide uncontrollably. This medicine is used as a single agent in treating patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation. It is also used along with trametinib in treating anaplastic thyroid cancer, non-small cell lung cancer with BRAF V600E mutation, and unresectable or metastatic solid tumours with BRAF V600E mutation.
Rafinlar 50 mg Capsule 28's contains Dabrafenib, which belongs to the class of medicines known as kinase inhibitors. It works by inhibiting the action of an enzyme (tyrosine kinase) and thus stops the abnormal growth of cancer cells.
Rafinlar 50 mg Capsule 28's may cause certain side effects such as diarrhoea, decreased appetite, nausea, vomiting, tiredness, itching, rash, headache, fever, acne, increased blood pressure, cough, and abdominal pain. Inform your doctor if any of these side effects bother you. Rafinlar 50 mg Capsule 28's should be taken as prescribed by your doctor. Do not take more than the recommended dose of medicine.
If you are allergic to Rafinlar 50 mg Capsule 28's or its components, inform your doctor. Before taking Rafinlar 50 mg Capsule 28's, inform your doctor if you have/had liver or kidney disease, calcium deficiency, heart problems, increased blood pressure, seizures, bleeding disorders, vision problems, and a history of blood clots. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy and breastfeeding.
Uses of Rafinlar 50 mg Capsule 28's
Medicinal Benefits
Rafinlar 50 mg Capsule 28's contains Dabrafenib, which is used in treating different types of cancer. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Rafinlar 50 mg Capsule 28's stops the body's production, spread and growth of cancerous cells.
Directions for Use
Side Effects of Rafinlar 50 mg Capsule 28's
Drug Warnings
To treat your condition effectually, continue taking Rafinlar 50 mg Capsule 28's for the period that your doctor has prescribed. Avoid taking Rafinlar 50 mg Capsule 28's if you are allergic to it or any other components present in it. Caution should be exercised if you have/had liver or kidney disease, heart disease, blood or bleeding disorders, diabetes, eye problems, or gastrointestinal disorders. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. Avoid driving and operating machines, as this medicine may cause visual disturbances. This medicine is not recommended for use in children below six years of age as the safety and efficacy are not established. Rafinlar 50 mg Capsule 28's may cause hypertension, thrombotic events, hemorrhagic events, cardiomyopathy, severe skin reactions, Glucose-6-phosphate Dehydrogenase Deficiency (G6PD), uveitis, tumor promotion in BRAF wild-type tumors, the occurrence of new malignancies, and hyperglycemia in some patients. Hence, inform your doctor about your complete medication and medical history before taking Rafinlar 50 mg Capsule 28's.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise